Price To Earnings Ratio 21.60 | Sector PE 60.62 |
PB Ratio 1.92 | Sector PB 7.85 |
EPS 10.68 | Dividend Yield 0.46 |
Today's Volume 74.163 K | 5 Day Avg. Volume 59.590 K |
PEG Ratio -0.70 | Market Cap. ₹ 2,270.00 Cr. |
Indoco Remedies Limited is an Indian pharmaceutical manufacturer. The company's field of activity is the production and distribution of preparations (ready-to-use dosage forms) and active pharmaceutical ingredients (API). The company offers drugs in several therapeutic categories, including diabetes, respiratory, dental, women's health, nutritional products, gastroenterology, cardiology, metabolic disorders and primary care. Its products/brands include Cyclopam, Sensodent-K, Karvol Plus, Sensoform, Cital UTI, Kidodent, Rexidin M, Lignox A, Dentogel, Aloja, Homide, Renolen, Noxa, Dexoren - S, Aloja M, ATM, Febrex Plus, Sensodent -KF, SM Fibro, MCBM 69, Cal Aid, Snowdent, Dropizin, Zincoren, Coloferrin, Bfloren, RR Sensoform Dental, Mofloren-D and Tuspel. The company serves both domestic and international markets. Its subsidiaries include Xtend Industrial Designers and Engineers Pvt Ltd, Indoco Remedies Czech sro. and Indoco Remedies UK Limited.